Mode
Text Size
Log in / Sign up

Hypertrophic Cardiomyopathy

Part of Cardiomyopathy

9 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Hypertrophic Cardiomyopathy

11 trials tracked for Hypertrophic Cardiomyopathy: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 77 citations.

11Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 3 Phase 1 2 Other / NA 3
  1. Phase 4 Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy Completed · 77 cited
  2. Phase 4 Ranolazine for the Treatment of Chest Pain in HCM Patients Completed
  3. Phase 3 Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem Completed
  4. Phase 2 Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy Completed
  5. Phase 2 Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy Completed
  6. Phase 2 Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER Completed
Show 5 more trials
  1. Phase 1 Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects Completed
  2. Phase 1 Hypertrophic Regression With N-Acetylcysteine in HCM Completed
  3. N/A Assessment of Left Ventricular Torsion by Echocardiography Study Completed
  4. N/A Study of Exercise Training in Hypertrophic Cardiomyopathy Completed
  5. N/A PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cardiomyopathy

Related studies from across the Cardiomyopathy family.

Vascular smooth muscle cell immune interactions drive remodeling across cardiovascular diseases
Oncology Sys. Review
Vascular smooth muscle cell immune interactions drive remodeling across cardiovascular diseases How blood vessel cells drive heart disease and high blood pressure
This narrative review synthesizes mechanisms of VSMC-immune interactions in atherosclerosis, hypertension, aortic aneurysms, and arteritis. …
A new review reveals how blood vessel cells change in heart disease, high blood pressure, and more.
Review of Diabetic Cardiomyopathy without reported trial data or specific outcomes
Cardiology Sys. Review
Review of Diabetic Cardiomyopathy without reported trial data or specific outcomes Review of Diabetic Cardiomyopathy offers new understanding of this heart condition
This narrative review addresses Diabetic cardiomyopathy but reports no specific population, sample size, or intervention details. The author…
This review looks at diabetic cardiomyopathy to help doctors understand this specific heart problem better for patients with diabetes.
Mini review examines sudden cardiac death risks in marathon runners across different age groups
Cardiology Sys. Review
Mini review examines sudden cardiac death risks in marathon runners across different age groups Marathon running links to higher heart risk in older men and full-distance participants
This mini review synthesizes evidence on sudden cardiac death (SCD) and coronary artery disease in marathon runners. The authors note that r…
A review of marathon runners shows heart risks vary by age, sex, and race distance, with most events happening near the finish.
Narrative review discusses Ganoderma lucidum polysaccharides for diabetes and related complications
Diabetes & Endocrinology Sys. Review
Narrative review discusses Ganoderma lucidum polysaccharides for diabetes and related complications New research shows mushroom compounds may help control blood sugar and fix organ damage
This narrative review examines the theoretical potential of Ganoderma lucidum polysaccharides (GLPs) for diabetes and associated conditions.
A common mushroom extract could help lower blood sugar and heal organ damage for millions of people with diabetes
Deep learning model screens for transthyretin amyloid cardiomyopathy using ECG images
Cardiology Cohort
Deep learning model screens for transthyretin amyloid cardiomyopathy using ECG images AI spots hidden heart disease from routine ECGs
This observational study developed a deep learning model to identify transthyretin amyloid cardiomyopathy from ECG images.
A new AI tool finds signs of a dangerous heart disease in routine ECGs years before symptoms worsen, offering hope for earlier treatment in …
Acoramidis associated with lower diuretic intensification in transthyretin amyloid cardiomyopathy
Cardiology Cohort
Acoramidis associated with lower diuretic intensification in transthyretin amyloid cardiomyopathy New Heart Drug Shows Lower Risk of Hospitalization vs Older Option
In this retrospective cohort study using US claims data, acoramidis was associated with a lower risk of diuretic intensification and a compo…
A new heart drug cut diuretic needs and hospitalizations more than the older option in early real-world use.
PSI-QPI metrics improved prediction of TTN-TV disease penetrance and expressivity in cardiomyopathy patients
Cardiology Cohort
PSI-QPI metrics improved prediction of TTN-TV disease penetrance and expressivity in cardiomyopathy patients New Tool Predicts Heart Failure Risk in Genetic Heart Disease
This cohort study evaluated PSI-DCM-LR-15, QPI, and PSI-QPI metrics in patients with cardiomyopathy due to TTN-TV and cardiac tissue from or…
A new combination of tests can more accurately predict which patients with genetic heart muscle disease will develop serious heart failure.
Thyroid dysfunction and atrial fibrillation risk in hypertrophic obstructive cardiomyopathy patients
Diabetes & Endocrinology Cohort
Thyroid dysfunction and atrial fibrillation risk in hypertrophic obstructive cardiomyopathy patients Thyroid Levels May Predict Heart Rhythm Problems in a Common Heart Condition
This observational cohort study of 755 HOCM patients examined the association between thyroid dysfunction and atrial fibrillation risk.
Monitoring thyroid function could become a simple way to help identify and manage heart rhythm risks in patients with a specific heart muscl…
Geranylgeranylacetone mitigates desmin variant-induced atrial cardiomyopathy mechanisms in vitro
Cardiology
Geranylgeranylacetone mitigates desmin variant-induced atrial cardiomyopathy mechanisms in vitro A Hidden Heart Flaw May Explain Some Early Atrial Fibrillation
This preclinical in vitro study evaluated HL-1 atrial cardiomyocytes expressing human desmin wild-type or pathogenic variants (p.S13F, p.N34…
A broken heart protein called desmin can silently damage the upper chambers and spark lifelong rhythm problems, while a potential rescue dru…
AI-assisted echocardiography shows moderate agreement with cardiologists in ATTR-CM monitoring
Cardiology
AI-assisted echocardiography shows moderate agreement with cardiologists in ATTR-CM monitoring AI Ultrasounds Match Experts for Tracking a Stealth Heart Disease
This retrospective observational study evaluated a fully automated, AI-assisted echocardiographic algorithm (Us2.ai) against human readers i…
AI heart scans match expert doctors for tracking a silent protein buildup, offering reliable monitoring for patients with a common form of h…
AI-derived echocardiographic measurements predict outcomes in transthyretin cardiomyopathy patients
Cardiology
AI-derived echocardiographic measurements predict outcomes in transthyretin cardiomyopathy patients AI Echo Scan Predicts Heart Failure Risk
This retrospective study evaluated 347 patients from two ATTR-CM registries to assess the prognostic value of AI-derived echocardiographic m…
A new computer program can spot warning signs of heart trouble in ATTR-CM patients better than current methods alone.
DCM Consortium PIs Rate Traditional Genetic Care Models More Acceptable Than Physician-Led Models
Cardiology
DCM Consortium PIs Rate Traditional Genetic Care Models More Acceptable Than Physician-Led Models Which way to test for heart disease feels right to doctors?
A cross-sectional needs assessment of 24 Principal Investigators in the DCM Consortium found traditional synchronous and asynchronous geneti…
Doctors prefer traditional in-person visits over remote options when checking for genetic heart risks, though care for this condition varies…

Questions about Hypertrophic Cardiomyopathy

Which echocardiographic and biochemical markers can predict mortality risk for children with hypertrophic cardiomyopathy?

In children with hypertrophic cardiomyopathy, echocardiographic markers like left atrial size and left ventricular wall thickness, and biochemical markers such as NT-proBNP, predict mortality risk.

Full answer →
Can visual standardized quantification of LGE help doctors see heart scarring better in hypertrophic cardiomyopathy?

Yes, VISTAQ, a visual standardized method, helps doctors see and quantify heart scarring (LGE) in HCM with excellent reproducibility, without needing complex software.

Full answer →